Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
The Paradoxical Reaction to Rituximab in Six Granulomatosis With Polyangiitis Patients: How Could It Be Explained and Managed? Publisher Pubmed



Alesaeidi S1 ; Piri SM1 ; Tavakolpour S2
Authors

Source: Current rheumatology reviews Published:2021


Abstract

BACKGROUND: Granulomatosis with polyangiitis is a systemic anti-neutrophil cytoplasmic antibody-associated vasculitides (AAVs), mainly involving the respiratory tract and renal system. Treatment by Rituximab as a next-generation therapy in ANCA-associated vasculitis is associated with promising outcomes in GPA patients. Despite symptoms improvements, disease recurrence and drug reaction are a challenging topic nowadays. OBJECTIVES: In this study, we examined six GPA patients who were confirmed to have paradoxical reactions to rituximab and then described how to control their symptoms. METHODS: In this study, all the systemic GPA patients (diagnosed based on ACR/EULAR criteria) who received RTX in Amir-Allam hospital were monitored for any sign of disease exacerbation up to 3 months after RTX exposure. RESULTS: From 78 GPA-diagnosed patients, six, including one man and five women with the mean age of 37.3 ± 13.8, were identified for exacerbation after RTX administration. CONCLUSION: According to our observation, it could be recommended not to deprive the patient of the benefits of RTX treatment due to the early patient's possible complications. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Related Docs
View other Related Docs
1. The Efficacy and Safety of Rituximab in Anca-Associated Vasculitis: A Systematic Review, Biology (2022)
2. Rituximab Versus Azathioprine in Maintenance Therapy of Patients With Granulomatosis With Polyangiitis, Caspian Journal of Internal Medicine (2025)
3. Two Decades Rituximab Therapy in Anti-Neutrophil Cytoplasmic Antibody Associated Vasculitis, Current Drug Targets (2025)
Experts (# of related papers)
View all Related Experts
Maryam Daneshpajooh (2)
Kamran Balighi (2)
Other Related Docs
4. Current Understanding and Unknown Aspects of the Treatment of Granulomatosis With Polyangiitis (Wegener’S Granulomatosis): Opportunities for Future Studies, Current Rheumatology Reviews (2020)
5. Successful Treatment Strategies in Granulomatosis With Polyangiitis-Associated Peripheral Ulcerative Keratitis, Cornea (2016)
6. Could Covid-19 Trigger Presentation or Exacerbation of Vasculitides? (A 14-Year-Old Girl With Newly Diagnosed Gpa After Covid-19 Infection), Iranian Journal of Pediatrics (2021)
7. Predicting Factors for Relapse in Patients With Granulomatosis With Polyangiitis: Results From a Long-Term Cohort, Clinical Rheumatology (2022)
8. Granulomatosis With Polyangiitis (Gpa) in a 15-Year-Old Girl With Facial Acne-Like Ulcers: A Case Report, Infectious Disorders - Drug Targets (2020)
9. A Phase Iii, Randomized, Two-Armed, Double-Blind, Parallel, Active Controlled, and Non-Inferiority Clinical Trial to Compare Efficacy and Safety of Biosimilar Adalimumab (Cinnora®) to the Reference Product (Humira®) in Patients With Active Rheumatoid Arthritis, Arthritis Research and Therapy (2017)
10. Rituximab Therapy for Adult Refractory Systemic Lupus Erythematosus With Neurological And/Or Psychiatric Presentations: A Prisma- Compliant Meta-Analysis, Current Rheumatology Reviews (2024)
11. Comparative Risk of Harm Associated With the Use of Targeted Immunomodulators: A Systematic Review, Arthritis Care and Research (2016)
12. Meta-Analysis of Pegfilgrastim Over Filgrastim in the Treatment of Chemotherapy-Induced Neutropenia, Annals of Cancer Research and Therapy (2020)
13. Safety, Tolerability, and Efficacy of Tocilizumab in Rheumatoid Arthritis: An Open-Label Phase 4 Study in Patients From the Middle East, International Journal of Rheumatology (2015)
14. Impact of Rituximab on Igg and Igm Levels in Patients With Autoimmune Bullous Diseases: A Cohort Study, Archives of Dermatological Research (2025)
15. Rituximab Administration in Coronavirus Pandemic Era: A Mini-Review of Clinical Evidence, Journal of Iranian Medical Council (2021)
16. Rowell Syndrome: A Comprehensive Review on Pathogenesis of a Rare and Challenging Entity and the Horizon of Targeted Therapeutics, Health Science Reports (2025)
17. A Comprehensive Review of Rituximab Therapy in Rheumatoid Arthritis Patients, Clinical Rheumatology (2019)
18. Adverse Drug Reactions of Rituximab in Patients Suffering From Autoimmune Neurological Diseases, DARU# Journal of Pharmaceutical Sciences (2022)
19. Efficacy and Safety of Immune Checkpoint Inhibitors and Cytokine Therapy in Autoimmune Diseases, Translational Autoimmunity: Treatment of Autoimmune Diseases (2022)
20. Rituximab Treatment and Improvement of Health-Related Quality of Life in Patients With Pemphigus, Cutis (2023)